The DEFR14C

New Post Public Reply Private Reply Replies (4) Message Board
Assiduous
887
The DEFR14C https://sec.report/Document/0001607062-21-000139/ now makes it very clear why the IPO is taking so long. When the NuGenerex dividend shares began trading on the OTC Pink under NUGX, all the NuGenerex common shares (750 million) would be alluded to by that ticker symbol since NuGenerex had only one common share class. The DEFR14C will now alter the NuGenerex charter to authorize two types of common shares, Class A and Class B each with their own provisions. Once the Classes are created, then NuGenerex can offer the Class B shares to the public, where the company will get the capital funding we know they need.

We also now have a clearer vision of the IPO timeline.
20 days after the DEFR14C shareholder notification + official corporation charter updating + final IPO prep
May 21 – June 10 Notification (calendar not business)
June 11 – June 18 Charter update (pure guess - no real idea on government red tape timelines)
June 21 – June 25 Final IPO prep (pure guess – I am assuming that all major work has or will be done by then)
June 28 – July 2 IPO launch

After the NuGenerex charter change, the two common share classes A & B would need official ticker symbols. Class A (ours) could stay as NUGX, name as good as any, and Class B will be NGIO. Class A NUGX will remain in the OTC Pink. Why, because the Class B NGIO is where NuGenerex will raise their funding. However, NUGX could become very active on the OTC before IPO in anticipation of the IPO because after all they are still valid shares of NuGenerex.

So why would new investors want to buy NGIO shares?
One: NGIO will be listed on NASDAQ (not the OTC)
Two: NGIO will be sold for $9 but have a guarantee liquidation value of $11
Three: NUGX is on the OTC Pink (need I say anymore)

I have been having a PM debate with a very wise person on who gets the IPO Warrants. The IPO S-1 says the NGIO will be sold in Units that have 1 Common B share plus 2 Warrants. The debate is:
Me: Units go from NuGenerex to the Underwriters who keep the Warrants and sell only the Common B shares to IPO buyers
Wise Debater: Units go directly to IPO buyers who get both Common B shares and the Warrants, underwriters are only bystanders?

If anyone gets to talk to Dawson James, please ask about this point. The difference is HUGE since one of the two Warrants allows the owner to get NGIO shares for free under certain circumstances.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 175

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 227

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 291

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 87

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 10

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 0

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

NEXE Innovations Unveils Impressive Q3 Financial Performance

Updated Category News Views 289

NEXE Innovations Reports Record Financial Growth WINDSOR, Ontario -- NEXE Innovations Inc. (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a leading player in compostable materials, is excited to share its financial results for the three-month period concluding on February 28, 2025. Showcasing its growth and robust strategies, NEXE has marked significant milestones,...

Continue Reading
Insights into Globus Medical's Upcoming Earnings Report

Updated Category News Views 179

Anticipation for Globus Medical's Earnings Report Globus Medical (NYSE: GMED) is preparing to unveil its quarterly earnings report soon. Investors are eager to discover the outcomes that could influence their investment decisions, and this report is no exception. With increasing excitement surrounding the earnings announcement, analysts project earnings per share (EPS) to...

Continue Reading
Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 278

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Royce Micro-Cap Trust Announces Q4 Distribution Details

Updated Category News Views 176

Royce Micro-Cap Trust Announces Fourth Quarter Distribution Royce Micro-Cap Trust, Inc. (NYSE-RMT) has proudly declared a significant fourth quarter distribution, amounting to $0.24 per share on its Common Stock. This distribution not only underscores the Trust's commitment to its shareholders but also allows them the option to receive the payout in cash or as additional...

Continue Reading
Cellectis Showcases Innovations in Non-Viral Gene Therapy at Congress

Updated Category News Views 214

Exciting Advances in Gene Therapy by Cellectis Cellectis, a clinical-stage biotechnology company, is making headlines with its innovative approach to gene therapy, particularly in the exciting world of gene editing. Recently, the company announced significant findings regarding the potential of circular single-stranded DNA (CssDNA) as a universal non-viral template for...

Continue Reading